Nath Bio-Genes (India) Ltd (NATHBIOGEN) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Nath Bio-Genes (India) Ltd reported sales of ₹328 Cr, operating profit of ₹35 Cr (OPM 11%) and net profit of ₹32 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
NATHBIOGEN quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 32 37 52 284 44 66 52 328 Expenses 27 29 52 254 38 62 47 293 Operating Profit 5 8 0 29 6 4 4 35 OPM 15% 22% 0.8% 10% 14% 5% 9% 11% Other Income 0 0 4 4 4 4 4 3 Interest 3 4 1 3 4 5 5 4 Depreciation 1 1 1 1 1 1 1 1 Profit before tax 1 4 2 29 5 2 2 33 Tax -3% 30% 30% 2% 12% 35% 100% 2% Net Profit 1 3 1 28 5 2 0 32 EPS in Rs 0.58 1.39 0.78 14.88 2.54 0.84 -0.01 16.98
NATHBIOGEN profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 230 234 248 268 445 490 Expenses 193 185 198 217 393 440 Operating Profit 37 49 50 51 52 49 OPM 16% 21% 20% 19% 12% 10% Other Income -87 1 4 4 14 15 Interest 11 10 9 11 16 17 Depreciation 3 3 3 4 4 4 Profit before tax -63 36 42 41 46 43 Tax 6% 3% 5% 5% 10% - Net Profit -67 35 40 39 42 39 EPS in Rs -35.46 18.43 20.85 20.31 21.91 20.35 Dividend Payout -6% 11% 10% 10% 9% -
NATHBIOGEN balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 19 19 19 19 19 Reserves 554 591 625 661 661 Borrowings 105 110 123 155 138 Other Liabilities 114 160 259 180 278 Total Liabilities 793 880 1,026 1,014 1,097 Fixed Assets 244 249 250 250 249 CWIP 0 0 0 0 0 Investments 5 6 6 6 6 Other Assets 543 625 770 759 842 Total Assets 793 880 1,026 1,014 1,097
NATHBIOGEN cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 17 38 75 18 -13 Cash from Investing Activity -20 -3 -27 -4 3 Cash from Financing Activity -22 -2 -8 -2 -4 Net Cash Flow -25 34 39 11 -13 Free Cash Flow 16 36 48 10 -16 CFO/OP 54% 80% 150% 37% -22%
NATHBIOGEN ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 136 152 139 121 70 Inventory Days - 4,388 - - - Days Payable - 586 - - - Cash Conversion Cycle 136 3,954 139 121 70 Working Capital Days 427 415 342 321 253 ROCE - 7% 7% 7% 7%